PSS41 - SECUKINUMAB SIGNIFICANTLY REDUCES PSORIASIS-RELATED WORK IMPAIRMENT AND INDIRECT COSTS COMPARED TO USTEKINUMAB AND ETANERCEPT IN TUNISIA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2541
https://www.valueinhealthjournal.com/article/S1098-3015(18)35843-1/fulltext
Title :
PSS41 - SECUKINUMAB SIGNIFICANTLY REDUCES PSORIASIS-RELATED WORK IMPAIRMENT AND INDIRECT COSTS COMPARED TO USTEKINUMAB AND ETANERCEPT IN TUNISIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35843-1&doi=10.1016/j.jval.2018.09.2541
First page :
Section Title :
Open access? :
No
Section Order :
1889